ATE114465T1 - Pharmazeutische zusammensetzung zur inhibierung der knochenresorption. - Google Patents
Pharmazeutische zusammensetzung zur inhibierung der knochenresorption.Info
- Publication number
- ATE114465T1 ATE114465T1 AT92121256T AT92121256T ATE114465T1 AT E114465 T1 ATE114465 T1 AT E114465T1 AT 92121256 T AT92121256 T AT 92121256T AT 92121256 T AT92121256 T AT 92121256T AT E114465 T1 ATE114465 T1 AT E114465T1
- Authority
- AT
- Austria
- Prior art keywords
- denotes
- bone resorption
- group
- chem
- pharmaceutical composition
- Prior art date
Links
- 208000006386 Bone Resorption Diseases 0.000 title abstract 2
- 230000024279 bone resorption Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 230000004097 bone metabolism Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 methoxyl group Chemical class 0.000 abstract 1
- 230000030991 negative regulation of bone resorption Effects 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33176791 | 1991-12-16 | ||
| JP23914492A JP3502403B2 (ja) | 1991-12-16 | 1992-09-08 | 骨吸収抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE114465T1 true ATE114465T1 (de) | 1994-12-15 |
Family
ID=26534099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92121256T ATE114465T1 (de) | 1991-12-16 | 1992-12-14 | Pharmazeutische zusammensetzung zur inhibierung der knochenresorption. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5317029A (de) |
| EP (1) | EP0547545B1 (de) |
| JP (1) | JP3502403B2 (de) |
| KR (1) | KR100257496B1 (de) |
| AT (1) | ATE114465T1 (de) |
| CA (1) | CA2085421A1 (de) |
| DE (1) | DE69200757T2 (de) |
| DK (1) | DK0547545T3 (de) |
| ES (1) | ES2066546T3 (de) |
| TW (1) | TW223016B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| US5389646A (en) * | 1993-12-30 | 1995-02-14 | Zymogenetics, Inc. | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
| GB9408577D0 (en) * | 1994-04-29 | 1994-06-22 | Fujisawa Pharmaceutical Co | New compound |
| US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
| US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
| US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| EP0783888A1 (de) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Verwendung von Troglitazone und verwandten Thiazolidinedionen zur Herstellung eines Medikaments für die Behandlung und Vorbeugung der Osteoporose |
| US7893021B2 (en) * | 1999-06-02 | 2011-02-22 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
| US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
| KR100389127B1 (ko) * | 2000-10-09 | 2003-06-25 | 동부한농화학 주식회사 | 벤조피라닐 헤테로고리 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물 |
| TWI396543B (zh) * | 2005-05-12 | 2013-05-21 | Sankyo Co | 取代丙烯醯胺衍生物及含有它之醫藥組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZM7682A1 (en) * | 1981-09-25 | 1983-05-23 | Beecham Group Plc | Active compounds |
| DE3364145D1 (de) * | 1982-04-08 | 1986-07-24 | Beecham Group Plc | Antihypertensive benzopyranols |
| EP0093535B1 (de) * | 1982-04-28 | 1986-12-30 | Beecham Group Plc | Chromenen und Chromanen |
| JPS58219183A (ja) * | 1982-04-28 | 1983-12-20 | ビ−チヤム・グル−プ・ピ−エルシ− | 新規なクロマノ−ル，その製法及びそれらを含む製薬組成物 |
| GB8513369D0 (en) * | 1985-05-28 | 1985-07-03 | Beecham Group Plc | Treatment |
| DE3703227A1 (de) * | 1987-02-04 | 1988-08-18 | Hoechst Ag | Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3823533A1 (de) * | 1988-07-12 | 1990-02-08 | Beiersdorf Ag | Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate |
-
1992
- 1992-09-08 JP JP23914492A patent/JP3502403B2/ja not_active Expired - Fee Related
- 1992-12-14 DE DE69200757T patent/DE69200757T2/de not_active Expired - Fee Related
- 1992-12-14 ES ES92121256T patent/ES2066546T3/es not_active Expired - Lifetime
- 1992-12-14 AT AT92121256T patent/ATE114465T1/de not_active IP Right Cessation
- 1992-12-14 EP EP92121256A patent/EP0547545B1/de not_active Expired - Lifetime
- 1992-12-14 US US07/990,617 patent/US5317029A/en not_active Expired - Fee Related
- 1992-12-14 DK DK92121256.9T patent/DK0547545T3/da active
- 1992-12-14 KR KR1019920024122A patent/KR100257496B1/ko not_active IP Right Cessation
- 1992-12-15 CA CA002085421A patent/CA2085421A1/en not_active Abandoned
- 1992-12-31 TW TW081110515A patent/TW223016B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2085421A1 (en) | 1993-06-17 |
| EP0547545B1 (de) | 1994-11-30 |
| JPH05221860A (ja) | 1993-08-31 |
| ES2066546T3 (es) | 1995-03-01 |
| JP3502403B2 (ja) | 2004-03-02 |
| DE69200757D1 (de) | 1995-01-12 |
| TW223016B (de) | 1994-05-01 |
| DK0547545T3 (da) | 1995-05-15 |
| KR100257496B1 (ko) | 2000-08-01 |
| KR930012036A (ko) | 1993-07-20 |
| US5317029A (en) | 1994-05-31 |
| DE69200757T2 (de) | 1995-05-11 |
| EP0547545A1 (de) | 1993-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1213296E (pt) | Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao | |
| NO981528L (no) | Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet | |
| DK0484094T3 (da) | Azasteroide forbindelser til behandling af prostatahypertrofi, deres fremstilling og anvendelse | |
| ATE114465T1 (de) | Pharmazeutische zusammensetzung zur inhibierung der knochenresorption. | |
| DE68924681D1 (de) | Heterocyclische Biphosphonsäurederivate. | |
| PH25859A (en) | Composition for treatment of ischemic disorder | |
| TWI265929B (en) | Triazinyl derivatives for inhibiting the production of IL-12 | |
| ATE289810T1 (de) | Ecteinascidinderivate | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| DK0488513T3 (da) | Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen | |
| DE69418744D1 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
| EP0385446A3 (de) | Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten | |
| DE69823240D1 (de) | Immunmodulierende arzneimittelzusammenstellung | |
| DK270889D0 (da) | Cytostatisk virksomme anthracyclinderivater, deres fremstilling og anvendelse | |
| BR9800956A (pt) | Composição farmacêutica que age por inibição das serinas proteases, e, medicamento | |
| ATE228134T1 (de) | Kondensierte pyrimidinderivate und diese enthaltende pharmazeutische zubereitungen | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| BR0014447A (pt) | Derivados de piperidina como inibidores da reabsorção | |
| BG103985A (en) | Multicyclic derivatives of erythromycin | |
| TW353071B (en) | Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |